Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

InspireMD Inc
XBER:II2

Watchlist Manager
InspireMD Inc Logo
InspireMD Inc
XBER:II2
Watchlist
Price: 5.843 EUR -2.42% Market Closed
Market Cap: €47.2m
Write Note Create Alert Ask AI

Relative Value

II2 price has not been updated for more than 7 years. This may indicate that the stock has been delisted.
II2 doesn't have a meaningful market cap.

The Relative Value of one II2 stock under the Base Case scenario is 10.797 EUR. Compared to the current market price of 5.843 EUR, InspireMD Inc is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

II2 Relative Value
Base Case
10.797 EUR
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

II2 Competitors Multiples
InspireMD Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
InspireMD Inc
XBER:II2
71.3m EUR 9.2 -1.5 -0.2 -0.2
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 38 27.5 33
US
Medline Inc
NASDAQ:MDLN
58.6B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
30B CHF 3.8 37.3 15.4 30
DK
Coloplast A/S
CSE:COLO B
110.7B DKK 3.9 27.1 14.1 16.9
US
Align Technology Inc
NASDAQ:ALGN
13.3B USD 3.3 32.5 17.3 22.4
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.9 13.2 21.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.4B CNY 9 24.9 22.4 22.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.7 19.6 92.4
CH
Ypsomed Holding AG
SIX:YPSN
4.1B CHF 5.2 21 13.7 18.5
KR
HLB Inc
KOSDAQ:028300
6.7T KRW 83 -30.5 -70.6 -66.8
P/E Multiple
Earnings Growth PEG
IL
InspireMD Inc
XBER:II2
Average P/E: 30.1
Negative Multiple: -1.5 		N/A N/A
JP
Hoya Corp
TSE:7741
38
13%
2.9
US
M
Medline Inc
NASDAQ:MDLN
Not Available
22%
N/A
CH
Alcon AG
SIX:ALC
37.3
25%
1.5
DK
Coloplast A/S
CSE:COLO B
27.1
22%
1.2
US
Align Technology Inc
NASDAQ:ALGN
32.5
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
29.9
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.9
9%
2.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.7 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21
32%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -30.5 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
InspireMD Inc
XBER:II2
Average EV/EBITDA: 17.9
Negative Multiple: -0.2 		N/A N/A
JP
Hoya Corp
TSE:7741
27.5
11%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available
6%
N/A
CH
Alcon AG
SIX:ALC
15.4
8%
1.9
DK
Coloplast A/S
CSE:COLO B
14.1
8%
1.8
US
Align Technology Inc
NASDAQ:ALGN
17.3
19%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
13.2
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.4
15%
1.5
CA
Bausch + Lomb Corp
NYSE:BLCO
19.6
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.7
21%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -70.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IL
InspireMD Inc
XBER:II2
Average EV/EBIT: 32.1
Negative Multiple: -0.2 		N/A N/A
JP
Hoya Corp
TSE:7741
33
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
14%
N/A
CH
Alcon AG
SIX:ALC
30
23%
1.3
DK
Coloplast A/S
CSE:COLO B
16.9
8%
2.1
US
Align Technology Inc
NASDAQ:ALGN
22.4
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
21.5
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.4
11%
2
CA
Bausch + Lomb Corp
NYSE:BLCO
92.4
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
18.5
29%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -66.8 N/A N/A

See Also

Summary
II2 intrinsic value, competitors valuation, and company profile.
DCF Valuation
II2 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
II2 stock valuation using valuation multiples.
Wall Street Estimates
II2 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
II2 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.